VANCOUVER, Jan. 7 /CNW/ - Protox Therapeutics Inc. (TSX-V:PRX), a leader
in advancing novel, targeted protein toxin therapeutics for the treatment of
cancer and other proliferative diseases, announced today that it has appointed
Mr. Tom D'Orazio as Vice President, Business Development and Strategy.
